ResMed Inc. |
Market Cap (3-Oct) $45,857,808,384 (13th) |
Close (30-Jun) $32.81 |
Volume (30-Jun) 1,098,777 |
Shortsold (28-Sep) 2,352,375 (0.40%) (347th) |
|
52w High $42.84 |
52w Low $25.42 |
P/E 18.76 |
EPS 1.49 |
[ARTICLE] ASX stocks at risk from Ozempic – and ResMed isn’t one of them
A news article has been posted about ResMed Inc. on the AFR. The article was published around , on 17 April 2024 at 10:13am.
Morgan Stanley brokers say the explosion of interest in the weight loss drugs will be far bigger than first thought. And these major companies could get hit.
Read ArticleRMD was $32.81 at the close of trade on 30 June 2023
| Recent Articles about ASX:RMD | |
|---|---|
| 20-Sep | ResMed ASX Deferral of Conversions Announcement - AFR
company-announcements.afr.com |
| 18-Sep | PolyNovo Appoints Dean Phizacklea and Andrew Price as Non ...
company-announcements.afr.com |
| 18-Sep | Australian United Investment Company Limited - AFR
company-announcements.afr.com |
| 18-Sep | FORM 4 - AFR
company-announcements.afr.com |
| 18-Sep | Statement of CDIs on issue - RMD - 07 Sep 2026 - Market Index
company-announcements.afr.com |
| 18-Sep | Accelerated Share Repurchase Agreement Announcement
company-announcements.afr.com |
| 8-Aug | Notification of dividend / distribution Appendix 3A.1 - Market Index
company-announcements.afr.com |
| 7-Aug | ResMed ASX Deferral of Conversions Announcement - August 2026
company-announcements.afr.com |
| 7-Aug | Resmed Inc. Announces Results for the Fourth Quarter of Fiscal ...
company-announcements.afr.com |
| 7-Aug | DJW NTA - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about ResMed Inc., including others on the AFR, on the media page.
You must be logged in to post a reply.